Elubrixin tosylate

Modify Date: 2024-01-16 17:13:42

Elubrixin tosylate structure	Common Name	Elubrixin tosylate
	CAS Number	960495-43-6	Molecular Weight	635.51200
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₄H₂₅Cl₂FN₄O₇S₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Elubrixin tosylate

Elubrixin tosylate (SB-656933 tosylate) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist. Elubrixin tosylate inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin tosylate has the potential for inflammatory diseases research, such as inflammatory bowel disease and airway inflammation[1][2][3].

Name	1-(2-chloro-3-fluorophenyl)-3-(4-chloro-2-hydroxy-3-piperazin-1-ylsulfonylphenyl)urea,4-methylbenzenesulfonic acid
Synonym	More Synonyms

Description	Elubrixin tosylate (SB-656933 tosylate) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist. Elubrixin tosylate inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin tosylate has the potential for inflammatory diseases research, such as inflammatory bowel disease and airway inflammation[1][2][3].
Related Catalog	Signaling Pathways >> Immunology/Inflammation >> Interleukin Related Signaling Pathways >> GPCR/G Protein >> CXCR Research Areas >> Inflammation/Immunology Signaling Pathways >> Immunology/Inflammation >> CXCR
Target	CXCR2 IL-8
In Vitro	Elubrixin has an inhibitory effect on neutrophils in a dose-dependent fashion[1].
References	[1]. Mozaffari S, et al. Inflammatory bowel disease therapies discontinued between 2009 and 2014. Expert Opin Investig Drugs. 2015;24(7):949-56. [2]. Lazaar AL, et al. SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. Br J Clin Pharmacol. 2011 Aug;72(2):282-93. [3]. Nicholson GC, et al. A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist. Pulm Pharmacol Ther. 2007;20(1):52-9.

Molecular Formula	C₂₄H₂₅Cl₂FN₄O₇S₂
Molecular Weight	635.51200
Exact Mass	634.05300
PSA	185.39000
LogP	6.83260

4-(6-chloro-3-[...

CAS#:688763-67-9

p-Toluenesulfon...

CAS#:104-15-4

Elubrixin tosylate

CAS#:960495-43-6

Literature: SMITHKLINE BEECHAM CORPORATION Patent: WO2007/150015 A2, 2007 ; Location in patent: Page/Page column 10-11 ; WO 2007/150015 A2

UNII-13FVR7WD4P

Elubrixin tosylate

DC Chemicals Limited
China
Product Name: Elubrixin tosylate
Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/500mg
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao

Get all suppliers and price by the below link:

Elubrixin tosylate suppliers

Price: ￥4190/10 mM * 1 mL in DMSO

Reference only. check more Elubrixin tosylate price

Elubrixin tosylate

Use of Elubrixin tosylate

Names

Elubrixin tosylate Biological Activity

Chemical & Physical Properties

Synthetic Route

Synonyms